@mike__kattan Profile picture

mk

@mike__kattan

tweets are my own

Similar User
Varadan Sevilimedu photo

@VSevilimedu

CTSC of Northern Ohio photo

@CTSC_NorthernOH

aurelius omlin photo

@AOmlin

Anne Reiner photo

@Anne_S_Reiner

Elena Elkin photo

@ElkinElena

Shaun Stauffer photo

@SStaufferPhD

Shuai Fu photo

@ShuaiFu2

mk Reposted

Nothing prettier to us than a full Bike to Cure starting line ready to take off! 😍 Have you registered yet? bit.ly/3gCfWq8

Tweet Image 1

Thanks for the clarification. I forgot our url changed

For anyone who hadn't realized yet, there is a new link for the web calculator to perform prediction model development sample size calculations according to @Richard_D_Riley et al's method riskcalc.org/samplesize/ #epitwitter



mk Reposted

The @socmdm Career Achievement Award winner is Michael Kattan @CCLRI #SMDM22 (4/4) Thank you to everyone who nominated members for our awards and congratulations to all of this year's winners! 🏆

Tweet Image 1

Great to see old friends!

So great to get together with friends after three years! #SMDM22

Tweet Image 1


mk Reposted

This week on the @ClevelandClinic Cancer Advances podcast I talk to @CleClinicMD radiation oncologist Rahul Tendulkar (@RTendulkarMD) and Chair Dept Quantitative Health Sciences @mike__kattan about use of nomograms for patients with #cancer my.clevelandclinic.org/podcasts/cance…


So great to get together with friends after three years! #SMDM22

Tweet Image 1


mk Reposted

Computable phenotype of disease health states transition probabilities b/w health states estimates real-world impact! @JKurowskiMD @JPAchkarMD @CCLRI bit.ly/3HLDUf2

Tweet Image 1

mk Reposted

We can already anticipate the (aging) objections, but the idea of re-branding at least a subset of GS6 seems to be picking up momentum. Feels like the right side of history :) @uroegg⁩ ⁦@aleberlin2⁩ ⁦@VickersBiostats@journotwitascopubs.org/doi/full/10.12…


mk Reposted

NEW PREPRINT Assessing performance and clinical usefulness in prediction models with survival outcomes: practical guidance for Cox proportional hazards models (with SAS and R code) medrxiv.org/content/10.110…

Tweet Image 1

mk Reposted

Most analyses that found response a surrogate ignore immortal time bias. Congratulations @sujataCLE and @DrGarciaAguilar for a rigorous analysis that avoids this common trap.

Response not a surrogate for survival in rectal cancer treated with NAT. Find why at academic.oup.com/oncolo/advance…



mk Reposted

Thank you @socmdm for this amazing honor! #SMDM21

The work from @BruceSchackman is extra acknowledge with the @socmdm Lusted student prize in Health Services, Outcomes, and Policy Research now named for Bruce Schackman! Congratulations 👏 #SMDM21

Tweet Image 1


mk Reposted

So many "regression versus machine learning" comparisons are not fair, as they don't allow non-linear trends for predictors in the regression model (eg using splines or polynomials). As such, they only serve to reveal a lack of understanding of good statistical practice


mk Reposted

Thanks for comments in @TheScientistLLC article Melvin (@cancerphysicist & @IBCradiation & @lecteroide). One thing that's confusing though: the HR for GARD (close to 1, as you point out, 0.98) is PER UNIT GARD -- this is a continuous analysis. cont. thelancet.com/journals/lanon…


mk Reposted

the point of the nomogram in figure 4 is to show this, but we put things back into the ABSOLUTE world of each disease (rather than the abstraction needed for the pooled analysis where everything was RELATIVE).

Tweet Image 1

mk Reposted

while each patient requires a different amount of physical dose to increase 1 unit of GARD (based on radiosensitivity), imagine a scenario where you dose-escalate a patient by 10 GARD, this would yield a predicted HR = 0.98^10 = 0.82 and so on for other GARD changes


mk Reposted

Estimating patients' individualized probability of an event of interest is challenging. A must-read book by Gerds and @mike__kattan clearly explains and guides you when developing and validating prediction models. #predictionmodels #machinelearning

Tweet Image 1

mk Reposted

TWEETORIAL on our new #radonc paper in @TheLancetOncol -- joint work from @CCLRI @MoffittNews @CWRUSOM 1/n Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis thelancet.com/journals/lanon… @OncoAlert



Loading...

Something went wrong.


Something went wrong.